semaj83/ctmatch_classification huggingface dataset:
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.25-0.417,  Meningitis Influenza Healthy subjects aged 3 to 5 months, normal intelligence The subjects' guardians are able to understand and sign the informed consent Healthy subjects confirmed by medical history questioning, physical examination and clinical decision and in accordance with vaccination requirements of the investigational vaccine Subjects who can comply with the requirements of the clinical trial program according to the researcher's views Subjects who have never received group A, C polysaccharide meningococcal vaccine and type b haemophilus Influenzal vaccine Subjects with temperature<=37°C on axillary setting  for the first vaccination Subject who has a medical history of Meningitis Subject who has a medical history of any of the following: allergies, seizures, epilepsy, encephalopathy history and so on Subject who is allergic with tetanus toxoid components Subject suffering from thrombocytopenia or other coagulation disorder may lead to contraindication to intramuscular injection Subject who has a history of allergic reactions Any known immunological dysfunction Had received gamma globulin or immune globulin, in the past two weeks Bleeding disorder diagnosed by a doctor or significant bruising or bleeding difficulties with IM injections or blood draws Any acute infections in last 7 days
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-72.0,  Hypothermia Newborn Estimated gestational age 37 weeks and greater Birth weight greater than 2,500gms Delivery in the hospital  Infant admitted to the NICU Birth weight less than 2,500gms Abdominal wall defect or myelomeningocele Major congenital anomalies Blistering skin disorder
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-80.0,  Allergies Twin participants ages 0 to 80 years who are with or without allergy disease  Patients with special risks attendant to venipuncture will be excluded
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Smoking Healthy female smokers ages 18 Read and write English Regularly smoke 5 or more cigarettes a day Sedentary, or not exercising greater than 20 minutes of vigorous exercise more than once a week or greater than 30 minutes of moderate exercise 2 times per week  known history of cardiovascular pulmonary or metabolic disease such as coronary artery disease, stroke, hypertension, chronic bronchitis, asthma, emphysema, and diabetes Any musculoskeletal problems that would limit exercise training such as knee or hip osteoarthritis or any other serious medical condition that might make exercise unsafe or unwise The current use of smokeless tobacco, nicotine replacement therapy or other smoking cessation treatment, and currently using prescription medication that might impair exercise performance or tolerance, specifically beta-blockers or medications used for the treatment of hypertension Pregnant or planning to become pregnant within the next 12 months Women hospitalized for a psychiatric disorder Receiving treatment for bipolar disorder or schizophrenia Current alcohol abuse or psychological problems when quitting in the past that required treatment
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-40.0,  Obesity Healthy females between the ages of 18-40 (inclusive) BMI > 27 kg/m² Regular menstrual cycle (28 ± 4 days with a maximum of 4 days within-subject variation in menstrual cycle duration Weight stable (within ± 3-kg) 2 months prior to study Must use barrier contraception (e.g. male/female condom) for the study's duration Must be willing to follow the prescribed diet/exercise plan for the study's duration  On hormonal contraceptives (IUD are allowed) or any other daily use of medications which can make the subject unsuitable for in the study Any significant health problem (history of cancer, HIV/AIDS, Diabetes, cardiovascular disease, untreated hypothyroidism, etc.) Restrictions against participating in cardiovascular exercise and strength training Any condition, which in the opinion of the investigator makes the subject unsuitable for in the study Women who are pregnant,lactating, or planning to become pregnant during the study period
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-75.0,  Infection Admission to Samsung Medical Center MICU and general wards for infectious diseases and hematology division Patients with SIRS (systemic inflammatory response syndrome) Intravenous vancomycin therapy deemed necessary  Age less than 20 years Age more than 75 years Current renal insufficiency defined as estimated Glomerular filtration rate < 50mg/min/1.73 m2 by MDRD equation History of adverse events to vancomycin 5. Pregnant woman
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 35.0-55.0,  Healthy Volunteer Healthy male volunteers, 35 to 55 years of age, inclusive Healthy status is defined by absence of evidence of any active or chronic disease following a detailed medical and surgical history, a complete physical examination including vital signs, 12-lead electrocardiogram (ECG), hematology, blood chemistry, serology and urinalysis A body mass index (BMI) between 18 to 30 kg/m2 inclusive Male volunteers and their partners of childbearing potential must use 2 methods of contraception, one of which must be a barrier method for the duration of the study and for 90 days after the last dose Able to participate and willing to give written informed consent and to comply with the study restrictions Non-smokers or have not smoked since at least 3 months prior to screening  If capable of reproduction, unwilling to use an effective form of contraception Suspicion of regular consumption of drug of abuse and/or positive drug or alcohol screen Infection with hepatitis B, hepatitis C, or human immunodeficiency virus 1 and 2 Systolic blood pressure greater than 140 or less than 90 mm Hg, and diastolic blood pressure greater than 90 or less than 50 mm Hg Resting pulse rate greater than 90 or less than 45 beats per minute Clinically significant abnormalities in laboratory test results Participation in an investigational drug or device study within 90 days prior to screening Donation of blood within 3 months prior to screening Concomitant disease or condition that could interfere with, or treatment of which might interfere with, the conduct of the study, or that would, in the opinion of the investigator, pose an unacceptable risk to the subject in this study
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Enhancement of Protective Antibody Response After Probiotic Consumption healthy male and female adult between 18 and 60 years old non menopausal female( with effective contraception) female non pregnant not wishing to be pregnat during the study capable to respect the protocol affialted to the social security system aggreeing to be registered in the national fileof volunteers  food allergy( component of the experimental product vaccines) manifestation of allergy vaccinated against flu during the 2 previous winters Food allergy, allergy to one of the component of the experimental products or allergy to one of the component of the flu vaccine Subject displaying manifestation of allergy or being treated for these Subject vaccinated against flu during the 2 previous winter (winter 2009-2010 and winter 2010-2011) Subject who had symptoms evocating flu during the previous winter (winter 2010-2011) Subject immunodepressed Subject with immunomodulatory treatment
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Recurrent Aphthous Stomatitis Both male and female aged 18 to 65 years old; 2. Patients diagnosed as minor recurrent aphthous stomatitis with the duration of each ulcer in excess of 5 days; 3. Fresh ulcers available with less than 72 hours eruption  Hypersensitive to various medical agents; 2. Concurrent acute infectious disease; 3. Pregnancy or lactation; 4. Concurrent other immunology disorders; 5. Accepting systemic administration of corticosteroids or immunosuppressive agents within 3 months; 6. Aphthous-like ulcers related to certain systemic disorders such as ulcerative colitis, Crohn's disease, Behcet's syndrome, serious anemia; 7. Aphthous-like ulcers related to drug such as non-steroidal anti-inflammatory drugs (NSAIDs) and anti-histamines; 8. Accepting anaesthetic therapy within 24 hours, or systemic antibiotics within 2 weeks, or other management for oral ulcers within 72 hours prior to the study; 9. Neoplasm patients; 10. Volunteers of other clinical trials on medical agents or toothpaste within one month
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-49.0,  Influenza Male or female aged 18 years Give written informed consent Healthy, as determined by medical history, physical examination, vital signs, and clinical safety laboratory examinations Females should not be pregnant and not lactating and fulfill one of the following At least one year post-menopausal;Surgically sterile;Will use oral, implantable, transdermal or injectable contraceptives for 30 days prior to first vaccination and until 28 days after vaccination Willing to use another reliable form of contraception approved by the Investigator for study duration and until 28 days after vaccination Women of childbearing potential must have a negative urine pregnancy test within 24 hours preceding receipt of vaccination Comprehension of the study requirements, expressed availability for the required study period, and ability to attend scheduled visits Willing to receive the unlicensed (VAX161) vaccine given as an i.m. injection Willing to provide multiple blood specimens collected by venipuncture
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-42.0,  Infertility Fertile women 1. Age 18-42 years 2. Regular ovulatory menstrual cycle 3. Previous spontaneous pregnancy to term 4. No history of subfertility 5. No underlying medical condition or immunosuppression 6. No history of hormonal medication or pregnancy in past two months 7. Capable of giving informed consent to participate in study 2. Non fertile women a.Age 18-42 years b.Regular ovulatory menstrual cycle c.Difficulty conceiving for greater than 12 months e.No underlying medical condition or immunosuppression f.No history of hormonal medication in past two months g.Capable of giving informed consent to participate in study  hormonal medication 2. pregnancy 3. not capable of giving consent 4. age <18 years or > 42 years 5. underlying medical condition
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Depressive Symptoms B-RICH Phase I, Pilot 1. Age 18 or older 2. Endorse one item on the PHQ-2 3. Able to be contacted by phone 4. Able to participate in the six, weekly 90-120 minute sessions of the Resiliency Classes 5. English or Spanish speaker B-RICH, Phase I Pilot  Under age 18 years 2. Endorse no items on PHQ-2 screener 3. PHQ-8 score of 15 or greater on the baseline interview 3) Unable to be contacted by phone 4) Unable to attend the weekly resiliency classes B-RICH Phase II, Randomized Trial 1. Age 18 or older 2. Endorse one of the first two items on the PHQ-8: "In the past two weeks, how often have you been bothered by 1) little interest or pleasure in doing things, 2) feeling down depressed or hopeless." 3. Able to be contacted by phone (voice or text message), e-mail, or Facebook. 4. Able to participate in the seven, weekly 90-120 minute sessions of the Resiliency Classes 5. English or Spanish speaker B-RICH Phase II, Randomized Trial Under age 18 years 2. PHQ-8 score of 20 or greater on the baseline interview 3. PHQ-8 score of 15 or greater and not currently in care and unwilling to get a referral for care 4. Currently homeless 5. Has a prior diagnosis of Bipolar Disorder 6. Has a prior diagnosis of Schizophrenia 7. Current alcohol and substance abuse 8. Unable to attend the weekly resiliency classes 9. Does not currently have a phone, an email address, or a Facebook profile
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Human Papillomavirus Infection Female subjects vaccinated with either HPV-1 or HPV-2 vaccines in Taiwan (hypothetical group)  Not applicable
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 40.0-60.0,  Obesity Healthy women aged 40 to 60 years 2. Are still experiencing regular menstrual cycles. 3. They must be willing to be randomized to placebo or GnRHAG therapy for 24 weeks 4. Be physically able to be randomized to participate in a programmed exercise training program. The investigators will consent up to 132 subjects with the aim of enrolling 22 in each of the 3 groups (placebo, GnRHAG, or GnRHAG+Exercise)  irregular menstrual cycles defined as 2 or more missed cycles in the previous year serum FSH >25 mIU/mL measured during the first 5 days of the menstrual cycle on hormonal contraceptive or menopausal therapy positive pregnancy test intention to become pregnant or start hormonal contraceptive therapy during the period of study lactation known hypersensitivity to GnRH or leuprolide acetate score >16 on the CESD((Center for Epidemiologic Studies Depression Scale ) severe osteopenia or osteoporosis (i.e., proximal femur or lumbar spine t scores < -2.0) abnormal vaginal bleeding
Patient description: A 42-year-old healthy woman came to the clinic to have her flu shot in early October. She works in a rehab center and has no underlying disease. It's her first time getting the vaccine this year. She is married for 5 years and uses barrier methods of contraception. Her menstrual cycle is irregular. She does not smoke. She is not on any medications. She exercises regularly for 30 minutes a day at least 5 days a week. She has no history of allergies to any food or drugs. Her past surgical history is significant for tonsillectomy and she is otherwise healthy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-64.0,  Influenza Aged 18 through 64 years on the day of Informed consent form (ICF) has been signed and dated Able to attend all scheduled visits and to comply with all trial procedures Subject is pregnant, or lactating, or of childbearing potential (to be considered of non-childbearing potential, a female must be post-menopausal for at least 1 year, surgically sterile, or using an effective method of contraception or abstinence from at least 4 weeks prior to vaccination and until at least 4 weeks after vaccination) Participation at the time of trial enrollment (or in the 4 weeks preceding the trial vaccination) or planned participation during the present trial period in another clinical trial investigating a vaccine, drug, medical device, or medical procedure Receipt of any vaccine in the 4 weeks preceding the trial vaccination or planned receipt of any vaccine in the 4 weeks following trial vaccination Vaccination against influenza in the past 6 months Receipt of immune globulins, blood or blood-derived products in the past 3 months Known or suspected congenital or acquired immunodeficiency; or receipt of immunosuppressive therapy, such as anti-cancer chemotherapy or radiation therapy, within the preceding 6 months; or long-term systemic corticosteroid therapy (prednisone or equivalent for more than 2 consecutive weeks within the past 3 months) Known systemic hypersensitivity to any of the vaccine components, or history of a life-threatening reaction to the vaccine used in the trial or to a vaccine containing any of the same substances